国药控股与恩华药业签署新一轮战略合作协议

同花顺09-10

近日，国药控股（HK1099）与恩华药业（002262）在上海举行战略合作沟通会，双方以“同行致远共赴新程”为主题，围绕准入协同、商销一体化、零售终端等方向深入交流，并签署新一轮战略合作协议。国药控股（HK1099）党委副书记、总裁连万勇，副总裁、总法律顾问、首席合规官胡立刚；恩华药业（002262）董事长孙彭生、总裁孙家权、副总裁成素巧出席会议。连万勇对恩华药业（002262）一行到访表示欢迎...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2666556434?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-10 17:40","share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","id":"2666556434","market":"sg","top_or_hot":-1,"title":"国药控股与恩华药业签署新一轮战略合作协议","media":"同花顺","content":"<div>\n<p>近日，国药控股（HK1099）与恩华药业（002262）在上海举行战略合作沟通会，双方以“同行致远 共赴新程”为主题，围绕准入协同、商销一体化、零售终端等方向深入交流，并签署新一轮战略合作协议。国药控股（HK1099）党委副书记、总裁连万勇，副总裁、总法律顾问、首席合规官胡立刚；恩华药业（002262）董事长孙彭生、总裁孙家权、副总裁成素巧出席会议。连万勇对恩华药业（002262）一行到访表示欢迎...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20260910/c679790430.shtml\">网页链接</a>\n\n</div>\n","source":"tonghuashun","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国药控股与恩华药业签署新一轮战略合作协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国药控股与恩华药业签署新一轮战略合作协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-10 17:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://stock.10jqka.com.cn/hks/20260910/c679790430.shtml><strong>同花顺</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，国药控股（HK1099）与恩华药业（002262）在上海举行战略合作沟通会，双方以“同行致远 共赴新程”为主题，围绕准入协同、商销一体化、零售终端等方向深入交流，并签署新一轮战略合作协议。国药控股（HK1099）党委副书记、总裁连万勇，副总裁、总法律顾问、首席合规官胡立刚；恩华药业（002262）董事长孙彭生、总裁孙家权、副总裁成素巧出席会议。连万勇对恩华药业（002262）一行到访表示欢迎...</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20260910/c679790430.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://stock.10jqka.com.cn/hks/20260910/c679790430.shtml","article_id":"2666556434","we_media_id":null,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260910/c679790430.shtml","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2666556434","pubTimestamp":1789033200,"columns":[],"sourceInfo":{"source_id":"tonghuashun","name":"同花顺"},"weMediaInfo":null,"summary":"近日，国药控股与恩华药业在上海举行战略合作沟通会，双方以“同行致远 共赴新程”为主题，围绕准入协同、商销一体化、零售终端等方向深入交流，并签署新一轮战略合作协议。国药控股党委副 ...","collect":0,"end_time":0,"defaultTopTitle":"10jqka.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0239":"医药制造","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0070":"员工持股","BK0188":"融资融券","002262":"恩华药业"},"translate_title":"Sinopharm Holdings and Enhua Pharmaceutical signed a new round of strategic cooperation agreement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002262":1.5},"content_text":"近日，国药控股（HK1099）与恩华药业（002262）在上海举行战略合作沟通会，双方以“同行致远 共赴新程”为主题，围绕准入协同、商销一体化、零售终端等方向深入交流，并签署新一轮战略合作协议。国药控股（HK1099）党委副书记、总裁连万勇，副总裁、总法律顾问、首席合规官胡立刚；恩华药业（002262）董事长孙彭生、总裁孙家权、副总裁成素巧出席会议。连万勇对恩华药业（002262）一行到访表示欢迎，充分肯定恩华药业（002262）在中枢神经系统等核心治疗领域的深厚积淀与产品竞争力。他指出，国药控股（HK1099）正加速推进一体化转型发展，聚焦重点品种医院（884301）准入协同、商销一体化服务和零售业务联动，依托国药控股（HK1099）零售及专业药房网络，不断拓宽院外用药场景，持续夯实工商战略合作根基。他表示，双方应充分释放各自资源优势，积极探索线上线下深度融合、数字化赋能的创新合作模式，共同开拓更广阔的市场空间。孙彭生表示，国药控股（HK1099）提出的合作方向与恩华药业（002262）的发展战略高度契合，此次战略合作协议的签署，是双方深化工（850102）商协同、共促产业高质量发展的重要里程碑。恩华药业（002262）愿与国药控股（HK1099）在麻精类优势品种准入、创新产品商业化落地、基层市场深度下沉、数字化运营协同等领域持续深化务实合作，推动优质药品更高效地触达临床一线与零售终端，期待双方携手打造工商合作标杆，实现优势互补、互利共赢。本次签约标志着双方战略合作迈入新阶段。下一步，双方将围绕准入协同、商销一体化、零售协同三大主线，加速推进恩华药业（002262）产品向基层市场下沉，充分发挥国药控股（HK1099）一体化网络优势与恩华创新产品体系优势，共同提升优质药品在医疗机构及零售终端的可及性与可负担性，更好地满足人民群众的用药需求。国药控股（HK1099）所属部分子公司代表，恩华药业（002262）营销公司代表参加会议。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2666556434","isCrawlerRequest":true}